Karin Pike-Overzet
Karin Pike-Overzet
Leiden University Medical Center
Verified email at lumc.nl
Title
Cited by
Cited by
Year
Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients
SJ Howe, MR Mansour, K Schwarzwaelder, C Bartholomae, M Hubank, ...
The Journal of clinical investigation 118 (9), 2008
11572008
New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling
WA Dik, K Pike-Overzet, F Weerkamp, D de Ridder, EFE de Haas, ...
The Journal of experimental medicine 201 (11), 1715-1723, 2005
3782005
Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia
I Homminga, R Pieters, AW Langerak, JJ de Rooi, A Stubbs, M Verstegen, ...
Cancer cell 19 (4), 484-497, 2011
3172011
Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy
A Deichmann, S Hacein-Bey-Abina, M Schmidt, A Garrigue, MH Brugman, ...
The Journal of clinical investigation 117 (8), 2225-2232, 2007
2722007
Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo
K Schwarzwaelder, SJ Howe, M Schmidt, MH Brugman, A Deichmann, ...
The Journal of clinical investigation 117 (8), 2241-2249, 2007
2272007
New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy
K Pike-Overzet, M Van Der Burg, G Wagemaker, JJ Van Dongen, ...
Molecular Therapy 15 (11), 1910-1916, 2007
1242007
Retroviral vector insertion sites associated with dominant hematopoietic clones mark “stemness” pathways
OS Kustikova, H Geiger, Z Li, MH Brugman, SM Chambers, CA Shaw, ...
Blood 109 (5), 1897-1907, 2007
992007
T-, B-and NK-lymphoid, but not myeloid cells arise from human CD34+CD38−CD7+ common lymphoid progenitors expressing lymphoid-specific genes
I Hoebeke, M De Smedt, F Stolz, K Pike-Overzet, FJT Staal, J Plum, ...
Leukemia 21 (2), 311-319, 2007
902007
Hematopoietic microRNA-126 protects against renal ischemia/reperfusion injury by promoting vascular integrity
R Bijkerk, C van Solingen, HC de Boer, P van der Pol, M Khairoun, ...
Journal of the American Society of Nephrology 25 (8), 1710-1722, 2014
862014
Ectopic retroviral expression of LMO2, but not IL2Rγ, blocks human T-cell development from CD34+ cells: implications for leukemogenesis in gene therapy
K Pike-Overzet, D de Ridder, F Weerkamp, MRM Baert, MMA Verstegen, ...
Leukemia 21 (4), 754-763, 2007
842007
Is IL2RG oncogenic in T-cell development?
K Pike-Overzet, D de Ridder, F Weerkamp, MRM Baert, MM Verstegen, ...
Nature 443 (7109), E5-E5, 2006
702006
Biology and novel treatment options for XLA, the most common monogenetic immunodeficiency in man
RW Hendriks, RGM Bredius, K Pike-Overzet, FJT Staal
Expert opinion on therapeutic targets 15 (8), 1003-1021, 2011
622011
Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer
K Pike-Overzet, M Rodijk, YY Ng, MRM Baert, C Lagresle-Peyrou, ...
Leukemia 25 (9), 1471-1483, 2011
612011
T-sing progenitors to commit
F Weerkamp, K Pike-Overzet, FJT Staal
Trends in immunology 27 (3), 125-131, 2006
592006
Aberrant Wnt signaling in leukemia
FJT Staal, F Famili, L Garcia Perez, K Pike-Overzet
Cancers 8 (9), 78, 2016
542016
Correction of B-cell development in Btk-deficient mice using lentiviral vectors with codon-optimized human BTK
YY Ng, MRM Baert, K Pike-Overzet, M Rodijk, MH Brugman, ...
Leukemia 24 (9), 1617-1630, 2010
402010
Isolation of human and mouse hematopoietic stem cells
YY Ng, MRM Baert, EFE de Haas, K Pike-Overzet, FJT Staal
Genetic Modification of Hematopoietic Stem Cells, 13-21, 2009
392009
Sustained engraftment of cryopreserved human bone marrow CD34+ cells in young adult NSG mice
AS Wiekmeijer, K Pike-Overzet, MH Brugman, DCF Salvatori, RM Egeler, ...
BioResearch open access 3 (3), 110-116, 2014
372014
Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia
S Rahman, M Magnussen, TE León, N Farah, Z Li, BJ Abraham, KZ Alapi, ...
Blood, The Journal of the American Society of Hematology 129 (24), 3221-3226, 2017
352017
Ex vivo expansion of hematopoietic stem cells for therapeutic purposes: lessons from development and the niche
P Tajer, K Pike-Overzet, S Arias, M Havenga, FJT Staal
Cells 8 (2), 169, 2019
322019
The system can't perform the operation now. Try again later.
Articles 1–20